Publicaciones en las que colabora con Mario Riverol Fernández (19)

2021

  1. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

    Brain Sciences, Vol. 11, Núm. 3

  2. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

2020

  1. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

    Movement Disorders, Vol. 35, Núm. 11, pp. 2009-2018

2019

  1. Amylin as a potential link between type 2 diabetes and alzheimer disease

    Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551

2015

  1. Descripción de una serie de pacientes con diagnóstico de enfermedad priónica

    Neurologia, Vol. 30, Núm. 3, pp. 144-152

  2. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 10, pp. 1522-1529

2014

  1. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway

    Neurobiology of Disease, Vol. 62, pp. 250-259

  2. Predictive factors of the response to treatment with onabotulinumtoxina in refractory migraine

    Revista de Neurologia, Vol. 58, Núm. 6, pp. 241-246

  3. Primary Whipple disease of the CNS presenting with chorea and dystonia: A video case report

    Neurology: Clinical Practice, Vol. 4, Núm. 6, pp. 508-510

2013

  1. Neuroimagen estructural y funcional en las enfermedades priónicas humanas

    Neurologia

2012

  1. Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys

    PLoS ONE, Vol. 7, Núm. 11

  2. Proyecto ReNACE. Convivencia de pacientes y familiares con la enfermedad de Parkinson: Resultados preliminares de la Fase I ReNACE Project

    Revista Cientifica de la Sociedad Espanola de Enfermeria Neurologica, Vol. 2012, Núm. 36, pp. 31-38

  3. Tomografía por emisión de positrones en la valoración del paciente neurológico

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 355-380

  4. Variant Creutzfeldt-Jakob disease occurring in mother and son

    Journal of Neurology, Neurosurgery and Psychiatry

  5. [Clinical experience of treatment with onabotulinumtoxin A in patients with refractory migraine].

    Revista de neurologia, Vol. 54, Núm. 12, pp. 705-711

2010

  1. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population

    European Journal of Neurology, Vol. 17, Núm. 2, pp. 321-325

2009

  1. 5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration

    Neurobiology of Disease, Vol. 33, Núm. 2, pp. 164-170

  2. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2006

  1. Neuroimagen en la enfermedad de Creutzfeldt-Jakob

    Neurologia, Vol. 21, Núm. 8, pp. 437-438